{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T03:27:38Z","timestamp":1771126058797,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T00:00:00Z","timestamp":1372723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            To investigate whether secretion of human \u03b2\u2010defensin 2 (\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102) is induced by bacillus\n                            <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                            almette\u2010\n                            <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>\n                            u\u00e9rin (\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            ) and to determine whether\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 affects\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            internalisation in bladder cancer cells.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Reverse transcription\u2010polymerase chain reaction analysis was used to determine whether\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102\n                            <jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content>\n                            increases after incubation with\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            .\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 proteins in 5637 and\n                            <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\n                            24 human bladder cancer cell lines were assayed by enzyme\u2010linked immunosorbent assay.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The internalisation rate was evaluated by double immunofluorescence assay and confocal microscopy to test the optimal dose of\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 for\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            internalisation.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            We also investigated the difference in internalisation rates and cell viability between recombinant\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 protein, anti\u2010\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 antibody, and\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 plus anti\u2010\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 antibody pretreatments.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            induced\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102\n                            <jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content>\n                            expression and\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 production dose and time\u2010dependently in bladder cancer cells and affected\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            internalisation.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Pretreatment with recombinant\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 protein lowered internalisation of\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            dose\u2010dependently. Moreover, anti\u2010\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 antibody prevented the effect of\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 on\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            internalisation in bladder cancer cells.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The internalisation rate of\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            pretreated with anti\u2010\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 antibody was higher than that in the control in 5637 (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.01) and T24 cells (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.05). The\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            internalisation rate in cells pretreated with anti\u2010\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 antibody plus recombinant\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 protein was higher than that in the control in 5637 (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.01) and T24 cells (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.05).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:italic>\n                              <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>\n                              ycobacterium bovis\n                            <\/jats:italic>\n                            \u2005\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            decreased bladder cancer cell viability, and anti\u2010\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 antibody prevented the inhibitory role of\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 on the anti\u2010proliferative effects of M.\n                            <jats:italic>bovis<\/jats:italic>\n                            \u2005\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            in bladder cancer cells\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Bladder cancer cells produce\n                            <jats:styled-content style=\"fixed-case\">HBD<\/jats:styled-content>\n                            \u20102 when they are infected by\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            to defend themselves against\n                            <jats:styled-content style=\"fixed-case\">BCG<\/jats:styled-content>\n                            internalisation, which plays an important role during the initiation and propagation of the immunotherapeutic response in bladder cancer cells.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.12196","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T10:13:39Z","timestamp":1372760019000},"page":"781-790","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Human \u03b2\u2010defensin 2 may inhibit internalisation of bacillus\n                    <scp>C<\/scp>\n                    almette\u2010\n                    <scp>G<\/scp>\n                    u\u00e9rin (\n                    <scp>BCG<\/scp>\n                    ) in bladder cancer cells"],"prefix":"10.1111","volume":"112","author":[{"given":"Jung Hoon","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Urology Chung\u2010Ang University College of Medicine  Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon\u2010Ja","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Urology Chung\u2010Ang University College of Medicine  Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Mee","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology Chung\u2010Ang University College of Medicine  Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Ho","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Urology Chung\u2010Ang University College of Medicine  Seoul Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,7,2]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"280","article-title":"Intravesical therapy for superficial bladder cancer","volume":"18","author":"Malkowicz SB","year":"2000","journal-title":"Semin Urol Oncol"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.2217\/1750743X.1.2.281"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636379"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-116"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1861"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.1999.5.265"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2006.04.001"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(19961201)25:4<381::AID-CYTO10>3.0.CO;2-R"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2006.08.009"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.4.1131"},{"key":"e_1_2_8_12_1","doi-asserted-by":"crossref","unstructured":"AliAS LanzM TownesCLet\u2009al.Release of the anti\u2010microbial peptide beta\u2010defensin 2 protects against attack by flagellatedEscherichia coliin human urothelium. European Association of Urology 27th Annual Congress 2012. Available at:http:\/\/www.uroweb.org\/events\/abstracts\u2010online\/?id=108&no_cache=1&AID=37373. Accessed April 2013","DOI":"10.1016\/S1569-9056(12)60181-X"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.11.040193.000541"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.8.4505-4511.2005"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2490-5-8"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)36774-5"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64744-1"},{"key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0022-5347(17)37532-8","article-title":"Dose\u2010response of bacillus Calmette\u2010Guerin in the treatment of superficial bladder cancer","volume":"147","author":"Morales A","year":"1992","journal-title":"J Urol"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)37707-8"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.04.062"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.10.32"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06026.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.12.097"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00365.2009"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01595-10"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)66410-5"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.12196","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.12196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:14:47Z","timestamp":1761743687000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.12196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,2]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1111\/bju.12196"],"URL":"https:\/\/doi.org\/10.1111\/bju.12196","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,2]]},"assertion":[{"value":"2013-07-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}